Most bought healthcare stocks in Q2 2021

See which Healthcare stocks institutional investors increased the most in Q2 2021, measured as net growth in reported share positions from Q1 2021 into Q2 2021. Notable additions at the top of this list include GILEAD SCIENCES INC (GILD), ZOMEDICA CORP (ZOM), INCYTE CORP (INCY), AGILON HEALTH INC (AGL). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
GILDGILEAD SCIENCES INC13,528,439$1.07M04408
ZOMZOMEDICA CORP13,371,960$11.12K10002
INCYINCYTE CORP8,867,103$781.09K02204
AGLAGILON HEALTH INC6,199,700$244.38K10001
MRNAMODERNA INC5,541,159$1.47M21013
OGNORGANON & CO4,114,378$2.29M50005
QSIQUANTUM-SI INC4,048,303$49.63K10001
SENSSENSEONICS HOLDINGS INC3,958,327$17.35K01001
IONSIONIS PHARMACEUTICALS INC3,954,462$128.69K02002
PFEPFIZER INC2,963,141$8.46M154012
NVSNOVARTIS AG-SPONSORED ADR2,863,054$525.01K15009
AHCOADAPTHEALTH CORP2,830,228$74.46K10102
BFLYBUTTERFLY NETWORK INC2,644,812$25.87K01001
OCGNOCUGEN INC2,440,756$19.60K10001
RXRXRECURSION PHARMACEUTICALS-A2,378,675$86.82K10001
BMYBRISTOL-MYERS SQUIBB CO2,329,213$5.34M187017
BMRNBIOMARIN PHARMACEUTICAL INC2,172,331$299.58K02104
JNJJOHNSON & JOHNSON2,100,018$149.93K1310019
BSXBOSTON SCIENTIFIC CORP1,677,938$182.23K01203
BEAMBEAM THERAPEUTICS INC1,660,663$448.20K01102
TDOCTELADOC HEALTH INC1,593,682$41.83K03003
DOCSDOXIMITY INC-CLASS A1,500,000$87.30K20002
LFSTLIFESTANCE HEALTH GROUP INC1,500,000$41.79K10001
MASS908 DEVICES INC1,381,491$43.07K01001
DAWNDAY ONE BIOPHARMACEUTICALS I1,341,396$30.54K10001
TEVATEVA PHARMACEUTICAL-SP ADR1,340,679-$114.47K12005
HOLXHOLOGIC INC1,264,956-$596.85K12104
SNYSANOFI-ADR1,263,608$289.78K04015
OPKOPKO HEALTH INC1,240,983$4.98K11003
EXASEXACT SCIENCES CORP1,174,795$74.69K01021
ALNYALNYLAM PHARMACEUTICALS INC1,092,374$309.81K01002
WBAWALGREENS BOOTS ALLIANCE INC1,010,016$42.09K04216
ABTABBOTT LABORATORIES966,078-$1.03M03217
BCRXBIOCRYST PHARMACEUTICALS INC965,010$15.64K01001
FATEFATE THERAPEUTICS INC963,275$119.64K11003
CTXRCITIUS PHARMACEUTICALS INC909,255$4.84K01001
ELVELEVANCE HEALTH INC907,217$539.87K03509
MLSSMILESTONE SCIENTIFIC INC871,628$2.06K01001
BDXBECTON DICKINSON AND CO830,153$105.26K046013
TXG10X GENOMICS INC-CLASS A795,916$209.17K01002
AKBAAKEBIA THERAPEUTICS INC757,149$3.30K01001
PHGKONINKLIJKE PHILIPS NVR- NY754,853$35.72K01001
ADPTADAPTIVE BIOTECHNOLOGIES732,867$50.12K01012
SEERSEER INC724,144$9.11K11002
ZLABZAI LAB LTD-ADR715,140$162.47K01011
ALLOALLOGENE THERAPEUTICS INC704,400$18.37K10001
RPTXREPARE THERAPEUTICS INC688,971$22.15K11002
ASRTASSERTIO HOLDINGS INC681,585$1.06K10001
THCTENET HEALTHCARE CORP679,494$69.50K01011
OSCROSCAR HEALTH INC - CLASS A674,019-$15.42K11002
20 symbols with net change in reported shares from tracked managers.0.003.7M7.4M11.2M14.9MNet change in reported shares (tracked managers)GILDZOMINCYAGLMRNAOGNQSISENSIONSPFENVSAHCOBFLYOCGNRXRXBMYBMRNJNJBSXBEAMSymbol

Frequently asked questions about Most bought healthcare stocks in Q2 2021

  • What are the most bought Healthcare stocks in Q2 2021?

    The most bought healthcare stocks in Q2 2021 are those with the largest increase in reported share counts across tracked institutional investors compared to Q1 2021, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q2 2021?

    Among the managers we track, net additions were largest in companies such as GILEAD SCIENCES INC (GILD), ZOMEDICA CORP (ZOM), INCYTE CORP (INCY), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2021).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.